Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Modulation of the CD4(+) T cell response after acellular pertussis vaccination in the presence of TLR4 ligation.

Brummelman J, Helm K, Hamstra HJ, van der Ley P, Boog CJ, Han WG, van Els CA.

Vaccine. 2015 Mar 17;33(12):1483-91. doi: 10.1016/j.vaccine.2015.01.063. Epub 2015 Feb 7.

PMID:
25659267
2.

Solid bioneedle-delivered influenza vaccines are highly thermostable and induce both humoral and cellular immune responses.

Soema PC, Willems GJ, van Twillert K, van de Wijdeven G, Boog CJ, Kersten GF, Amorij JP.

PLoS One. 2014 Mar 26;9(3):e92806. doi: 10.1371/journal.pone.0092806. eCollection 2014.

3.

Bordetella pertussis proteins dominating the major histocompatibility complex class II-presented epitope repertoire in human monocyte-derived dendritic cells.

Stenger RM, Meiring HD, Kuipers B, Poelen M, van Gaans-van den Brink JA, Boog CJ, de Jong AP, van Els CA.

Clin Vaccine Immunol. 2014 May;21(5):641-50. doi: 10.1128/CVI.00665-13. Epub 2014 Mar 5.

4.

Age related differences in dynamics of specific memory B cell populations after clinical pertussis infection.

van Twillert I, van Gaans-van den Brink JA, Poelen MC, Helm K, Kuipers B, Schipper M, Boog CJ, Verheij TJ, Versteegh FG, van Els CA.

PLoS One. 2014 Jan 13;9(1):e85227. doi: 10.1371/journal.pone.0085227. eCollection 2014.

5.

Loss of multi-epitope specificity in memory CD4(+) T cell responses to B. pertussis with age.

Han WG, van Twillert I, Poelen MC, Helm K, van de Kassteele J, Verheij TJ, Versteegh FG, Boog CJ, van Els CA.

PLoS One. 2013 Dec 31;8(12):e83583. doi: 10.1371/journal.pone.0083583. eCollection 2013.

6.

Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults.

Verdijk P, Rots NY, van Oijen MG, Oberste MS, Boog CJ, Okayasu H, Sutter RW, Bakker WA.

Vaccine. 2013 Nov 12;31(47):5531-6. doi: 10.1016/j.vaccine.2013.09.021. Epub 2013 Sep 21.

PMID:
24063976
7.

Expression of human CEACAM1 in transgenic mice limits the Opa-specific immune response against meningococcal outer membrane vesicles.

Zariri A, van Dijken H, Hamstra HJ, van der Flier M, Vidarsson G, van Putten JP, Boog CJ, van den Dobbelsteen G, van der Ley P.

Vaccine. 2013 Nov 12;31(47):5585-93. doi: 10.1016/j.vaccine.2013.07.069. Epub 2013 Aug 6.

PMID:
23933369
8.

Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults.

Soonawala D, Verdijk P, Wijmenga-Monsuur AJ, Boog CJ, Koedam P, Visser LG, Rots NY.

Vaccine. 2013 Aug 12;31(36):3688-94. doi: 10.1016/j.vaccine.2013.05.104. Epub 2013 Jun 13.

PMID:
23770332
9.

Protection against allergic airway inflammation during the chronic and acute phases of Trichinella spiralis infection.

Aranzamendi C, de Bruin A, Kuiper R, Boog CJ, van Eden W, Rutten V, Pinelli E.

Clin Exp Allergy. 2013 Jan;43(1):103-15. doi: 10.1111/cea.12042.

PMID:
23278885
10.

Resurgence of pertussis calls for re-evaluation of pertussis animal models.

van der Ark AA, Hozbor DF, Boog CJ, Metz B, van den Dobbelsteen GP, van Els CA.

Expert Rev Vaccines. 2012 Sep;11(9):1121-37. doi: 10.1586/erv.12.83. Review.

PMID:
23151168
11.

Pre-existing virus-specific CD8(+) T-cells provide protection against pneumovirus-induced disease in mice.

van Helden MJ, van Kooten PJ, Bekker CP, Gröne A, Topham DJ, Easton AJ, Boog CJ, Busch DH, Zaiss DM, Sijts AJ.

Vaccine. 2012 Oct 5;30(45):6382-8. doi: 10.1016/j.vaccine.2012.08.027. Epub 2012 Aug 29.

12.

The bone marrow functions as the central site of proliferation for long-lived NK cells.

van Helden MJ, de Graaf N, Boog CJ, Topham DJ, Zaiss DM, Sijts AJ.

J Immunol. 2012 Sep 1;189(5):2333-7. doi: 10.4049/jimmunol.1200008. Epub 2012 Jul 20.

13.

Impaired production of TNF-α by dendritic cells of older adults leads to a lower CD8+ T cell response against influenza.

Liu WM, Nahar TE, Jacobi RH, Gijzen K, van Beek J, Hak E, Jonges M, Boog CJ, van der Zeijst BA, Soethout EC.

Vaccine. 2012 Feb 21;30(9):1659-66. doi: 10.1016/j.vaccine.2011.12.105. Epub 2012 Jan 9.

PMID:
22230585
14.

From immunology to vaccinology: a journey of trial and error towards more rational design.

Boog CJ.

Hum Vaccin. 2011 Sep;7(9):896-9. doi: 10.4161/hv.7.9.17966. Epub 2011 Sep 1. No abstract available.

PMID:
21892011
15.

Immunoproteasome-deficiency has no effects on NK cell education, but confers lymphocytes into targets for NK cells in infected wild-type mice.

van Helden MJ, de Graaf N, Bekker CP, Boog CJ, Zaiss DM, Sijts AJ.

PLoS One. 2011;6(8):e23769. doi: 10.1371/journal.pone.0023769. Epub 2011 Aug 24.

16.

A cyclic undecamer peptide mimics a turn in folded Alzheimer amyloid β and elicits antibodies against oligomeric and fibrillar amyloid and plaques.

Hoogerhout P, Kamphuis W, Brugghe HF, Sluijs JA, Timmermans HA, Westdijk J, Zomer G, Boog CJ, Hol EM, van den Dobbelsteen GP.

PLoS One. 2011 Apr 19;6(4):e19110. doi: 10.1371/journal.pone.0019110.

17.

Fast, antigen-saving multiplex immunoassay to determine levels and avidity of mouse serum antibodies to pertussis, diphtheria, and tetanus antigens.

Stenger RM, Smits M, Kuipers B, Kessen SF, Boog CJ, van Els CA.

Clin Vaccine Immunol. 2011 Apr;18(4):595-603. doi: 10.1128/CVI.00061-10. Epub 2011 Feb 16.

18.

Aging and impaired immunity to influenza viruses: implications for vaccine development.

Liu WM, van der Zeijst BA, Boog CJ, Soethout EC.

Hum Vaccin. 2011 Jan-Feb;7 Suppl:94-8. Epub 2011 Jan 1. Review.

PMID:
21301210
19.

Differential effect of TLR2 and TLR4 on the immune response after immunization with a vaccine against Neisseria meningitidis or Bordetella pertussis.

Fransen F, Stenger RM, Poelen MC, van Dijken HH, Kuipers B, Boog CJ, van Putten JP, van Els CA, van der Ley P.

PLoS One. 2010 Dec 23;5(12):e15692. doi: 10.1371/journal.pone.0015692.

20.

Phacilitate, Barcelona Vaccine Forum 2010: focus on correlates of protection against influenza.

Soethout EC, Bakker WA, van Dam RH, Rots NY, Boog CJ.

Hum Vaccin. 2010 Dec;6(12):964-5. Epub 2010 Dec 1. No abstract available.

PMID:
21150272
21.

Considerations in the design of vaccines that induce CD8 T cell mediated immunity.

Zaiss DM, Boog CJ, van Eden W, Sijts AJ.

Vaccine. 2010 Nov 16;28(49):7716-22. doi: 10.1016/j.vaccine.2010.08.101. Epub 2010 Sep 17. Review.

PMID:
20851090
22.

Impaired long-term maintenance and function of Bordetella pertussis specific B cell memory.

Stenger RM, Smits M, Kuipers B, van Gaans-van den Brink J, Poelen M, Boog CJ, van Els CA.

Vaccine. 2010 Sep 14;28(40):6637-46. doi: 10.1016/j.vaccine.2010.06.118. Epub 2010 Jul 15.

PMID:
20637762
23.

The structure of Neisseria meningitidis lipid A determines outcome in experimental meningococcal disease.

Fransen F, Hamstra HJ, Boog CJ, van Putten JP, van den Dobbelsteen GP, van der Ley P.

Infect Immun. 2010 Jul;78(7):3177-86. doi: 10.1128/IAI.01311-09. Epub 2010 May 3.

24.

Hepatitis B vaccination strategies tailored to different endemicity levels: some considerations.

Rots NY, Wijmenga-Monsuur AJ, Luytjes W, Kaaijk P, de Graaf TW, van der Zeijst BA, Boog CJ.

Vaccine. 2010 Jan 22;28(4):893-900. doi: 10.1016/j.vaccine.2009.10.125. Epub 2009 Nov 20. Review.

PMID:
19932217
25.

Naturally occurring lipid A mutants in neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy.

Fransen F, Heckenberg SG, Hamstra HJ, Feller M, Boog CJ, van Putten JP, van de Beek D, van der Ende A, van der Ley P.

PLoS Pathog. 2009 Apr;5(4):e1000396. doi: 10.1371/journal.ppat.1000396. Epub 2009 Apr 24.

26.

Principles of vaccination and possible development strategies for rational design.

Boog CJ.

Immunol Lett. 2009 Feb 21;122(2):104-7. doi: 10.1016/j.imlet.2008.11.009. Epub 2008 Dec 25. Review.

PMID:
19100778
27.

Immunodominance in mouse and human CD4+ T-cell responses specific for the Bordetella pertussis virulence factor P.69 pertactin.

Stenger RM, Poelen MC, Moret EE, Kuipers B, Bruijns SC, Hoogerhout P, Hijnen M, King AJ, Mooi FR, Boog CJ, van Els CA.

Infect Immun. 2009 Feb;77(2):896-903. doi: 10.1128/IAI.00769-08. Epub 2008 Nov 17.

28.
29.

Stable isotope tagging of epitopes: a highly selective strategy for the identification of major histocompatibility complex class I-associated peptides induced upon viral infection.

Meiring HD, Soethout EC, Poelen MC, Mooibroek D, Hoogerbrugge R, Timmermans H, Boog CJ, Heck AJ, de Jong AP, van Els CA.

Mol Cell Proteomics. 2006 May;5(5):902-13. Epub 2006 Jan 23.

30.

Mass tag-assisted identification of naturally processed HLA class II-presented meningococcal peptides recognized by CD4+ T lymphocytes.

Meiring HD, Kuipers B, van Gaans-van den Brink JA, Poelen MC, Timmermans H, Baart G, Brugghe H, van Schie J, Boog CJ, de Jong AP, van Els CA.

J Immunol. 2005 May 1;174(9):5636-43.

31.

Toward a myeloablative regimen with clinical potential: II. Treosulfan induces specific skin graft tolerance across haploidentical MHC barriers.

van Pel M, van Breugel DW, Vos W, Ploemacher RE, Boog CJ.

Bone Marrow Transplant. 2004 Jan;33(2):153-9.

PMID:
14661037
32.

Donor-specific tolerance in a murine model: the result of extra-thymic T cell deletion?

van Pel M, van Breugel DW, van Wijk M, Luypen S, Vingerhoed J, Roholl PJ, Boog CJ.

Transpl Immunol. 2003 Jul-Sep;11(3-4):375-84.

PMID:
12967790
34.

Permanent acceptance of both cardiac and skin allografts using a mild conditioning regimen for the induction of stable mixed chimerism in mice.

van Pel M, Hilbrands L, Smits D, van Breugel DW, van Eck M, Boog CJ.

Transpl Immunol. 2003 Jan-Mar;11(1):57-63.

PMID:
12727476
35.

Ultrastructural characterization of effector-target interactions for human neonatal and adult NK cells reveals reduced intercellular surface contacts of neonatal cells.

Ribeiro-do-Couto LM, Poelen M, Hooibrink B, Dormans JA, Roholl PJ, Boog CJ.

Hum Immunol. 2003 May;64(5):490-6.

PMID:
12691699
36.

Autoreactivity against induced or upregulated abundant self-peptides in HLA-A*0201 following measles virus infection.

Herberts CA, van Gaans-van den Brink J, van der Heeft E, van Wijk M, Hoekman J, Jaye A, Poelen MC, Boog CJ, Roholl PJ, Whittle H, de Jong AP, van Els CA.

Hum Immunol. 2003 Jan;64(1):44-55.

PMID:
12507814
37.

Identification of immunodominant epitopes derived from the respiratory syncytial virus fusion protein that are recognized by human CD4 T cells.

van Bleek GM, Poelen MC, van der Most R, Brugghe HF, Timmermans HA, Boog CJ, Hoogerhout P, Otten HG, van Els CA.

J Virol. 2003 Jan;77(2):980-8.

38.

Dynamics of measles virus protein expression are reflected in the MHC class I epitope display.

Herberts CA, Meiring HM, van Gaans-van den Brink JA, van der Heeft E, Poelen MC, Boog CJ, de Jong AP, van Els CA.

Mol Immunol. 2003 Jan;39(10):567-75.

PMID:
12431390
39.

High IL-13 production by human neonatal T cells: neonate immune system regulator?

Ribeiro-do-Couto LM, Boeije LC, Kroon JS, Hooibrink B, Breur-Vriesendorp BS, Aarden LA, Boog CJ.

Eur J Immunol. 2001 Nov;31(11):3394-402.

40.

Influence of infection of cells with bacteria associated with reactive arthritis on the peptide repertoire presented by HLA-B27.

Ringrose JH, Muijsers AO, Pannekoek Y, Yard BA, Boog CJ, van Alphen L, Dankert J, Feltkamp TE.

J Med Microbiol. 2001 Apr;50(4):385-9.

PMID:
11289525
41.

Mechanisms of donor-specific tolerance in a skin transplantation model.

van Pel M, Vingerhoed J, de Vries-van der Zwan A, van der Pol MA, Boog CJ.

Transplant Proc. 2001 Feb-Mar;33(1-2):152-3. No abstract available.

PMID:
11266754
42.

Immunologic monitoring of the beneficial effect of one HLA-DR-shared blood transfusion in heart transplant patients.

Vaessen LM, van Miert PP, van der Mast BJ, Doumaid K, Balk AH, Boog CJ, Weimar W.

J Heart Lung Transplant. 2000 Nov;19(11):1098-107.

PMID:
11077228
43.

T- and B-cell nonresponsiveness to self-alphaB-crystallin in SJL mice prevents the induction of experimental allergic encephalomyelitis.

van Stipdonk MJ, Willems AA, Verbeek R, Boog CJ, van Noort JM.

Cell Immunol. 2000 Sep 15;204(2):128-34.

PMID:
11069720
44.

Variable leukocyte composition of red blood cell concentrates prepared in top-bottom systems: possible implications for pre-transplant blood transfusion.

Weinreich SS, Remmerswaal EB, Laport R, van Rhenen DJ, Rombout-Sastrienkova E, Smit Sibinga CT, Vrielink H, Boog CJ.

Vox Sang. 2000;79(2):83-6.

PMID:
11054045
45.

Modulation of the T cell receptor beta chain repertoire after heart transplantation.

Doumaid K, van Miert PP, Vaessen LM, Remmerswaal EB, Weimar W, Boog CJ.

Transpl Immunol. 2000 Jun;8(2):83-94.

PMID:
11005313
46.

Tolerance controls encephalitogenicity of alphaB-crystallin in the Lewis rat.

van Stipdonk MJ, Willems AA, Plomp AC, van Noort JM, Boog CJ.

J Neuroimmunol. 2000 Mar 1;103(2):103-11.

PMID:
10696905
47.

An alternative conditioning regimen for induction of specific skin graft tolerance across full major histocompatibility complex barriers.

de Vries-van der Zwan A, van der Pol MA, de Waal LP, Boog CJ.

Transpl Immunol. 1998 Sep;6(3):147-51.

PMID:
9848220
48.

Long-term detection of microchimaerism in peripheral blood after pretransplantation blood transfusion.

Vervoordeldonk SF, Doumaid K, Remmerswaal EB, ten Berge IJ, Wilmink JM, de Waal LP, Boog CJ.

Br J Haematol. 1998 Sep;102(4):1004-9.

PMID:
9734651
49.

Specific tolerance induction and organ transplantation.

de Vries-van der Zwan A, Besseling AC, van der Pol MA, de Waal LP, Boog CJ.

Leuk Lymphoma. 1998 Sep;31(1-2):131-42. Review.

PMID:
9720723
50.

T cells discriminate between differentially phosphorylated forms of alphaB-crystallin, a major central nervous system myelin antigen.

van Stipdonk MJ, Willems AA, Amor S, Persoon-Deen C, Travers PJ, Boog CJ, van Noort JM.

Int Immunol. 1998 Jul;10(7):943-50.

PMID:
9701032

Supplemental Content

Support Center